Cargando…
microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4
Background: Aberrant expression of microRNAs (miRNAs) in non-small-cell lung cancer (NSCLC) has been reported. Dysregulation of miRNAs exerts tumor-suppressing or tumor-promoting actions on the pathology and biological behaviors of NSCLC. miR-612 is associated with many types of human cancer; howeve...
Autores principales: | Kang, Xiaowen, Kong, Fanwu, Wu, Shijie, Liu, Qiushuang, Yang, Chengcheng, Wu, Xiaomei, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549771/ https://www.ncbi.nlm.nih.gov/pubmed/31213835 http://dx.doi.org/10.2147/OTT.S204004 |
Ejemplares similares
-
microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction]
Publicado: (2021) -
Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression
por: Liu, Mengnan, et al.
Publicado: (2018) -
MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1
por: Jin, Yang, et al.
Publicado: (2020) -
Overexpression of microRNA-612 Restrains the Growth, Invasion, and Tumorigenesis of Melanoma Cells by Targeting Espin
por: Zhu, Ying, et al.
Publicado: (2018) -
Bromodomain-containing protein 4 silencing by microRNA-765 produces anti-ovarian cancer cell activity
por: Ji, Yong-Jun, et al.
Publicado: (2021)